Skip to main content

Latest News

November 19, 2026
Bristol Myers Squibb Demonstrates Breadth and Clinical Momentum Across Blood Cancers and Rare Hematologic Disorders at ASH 2026
November 18, 2026
Bristol Myers Squibb Presents First Clinical Data from Two Phase 3 Studies in the ADEPT Program Evaluating KarXT for Psychosis Associated with Alzheimer’s Disease
November 12, 2026
Bristol Myers Squibb Announces Evolution of Research & Development Organization

Latest Events

Event year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
October 29, 2026 08:00 AM ET
Bristol Myers Squibb Q3 2026 Results Conference Call
Webcast (opens in new window)
  • Press Release (PDF)
  • Quarterly Package of Financial Information (XLS)
  • Q3 2026 Results Presentation (PDF)
  • Q3 2026 Results Presentation (with Appendix)(PDF)
  • Preliminary Q3 2026 Acquired IPRD & Licensing Income (PDF)
July 30, 2026 08:15 AM ET
Bristol Myers Squibb Q2 2026 Results Conference Call
Webcast (opens in new window)
  • Press Release (PDF)
  • Quarterly Package of Financial Information (XLS)
  • Q2 2026 Results Presentation (PDF)
  • Q2 2026 Results Presentation (with Appendix) (PDF)
  • Preliminary Q2 2026 Acquired IPRD & Licensing Income (PDF)
June 9, 2026 02:00 PM EST
Goldman Sachs 47th Annual Global Healthcare Conference
Webcast (opens in new window)